Posts by odiadmin

Fifth U.S. Patent Granted

Fifth patent allowance issued in the United States, toward the use of topical dipyridamole for the treatment of melanocytic nevus, cataracts, and ocular melanoma.

Read More

Fourth U.S. Patent Granted

Fourth patent allowance issued in the United States, the for the use of dipyridamole in the following indications: keratitis, corneal abrasions, and corneal ulcers

Read More

Patent Granted in China

Patent allowance issued in China for the indications of Dry Eye Disease, Sjogren’s Syndrome, Pterygium,  Pinguecula, and Corneal Neovascularization

Read More